Vanda Pharmaceuticals, Inc. (VNDA)
6.15
+0.01
(+0.16%)
USD |
NASDAQ |
Dec 09, 13:58
Vanda Pharmaceuticals Market Cap: 363.44M for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 4.610B |
| ADMA Biologics, Inc. | 4.717B |
| Aldeyra Therapeutics, Inc. | 293.59M |
| Exelixis, Inc. | 11.19B |
| Anavex Life Sciences Corp. | 391.34M |
Market Cap Related Metrics
| PS Ratio | 1.703 |
| PEG Ratio | -0.0105 |
| Price to Book Value | 0.7800 |
| Price | 6.15 |
| Earnings Yield | -23.28% |
| PEGY Ratio | -0.0105 |